切换至 "中华医学电子期刊资源库"
高级检索
中华危重症医学杂志(电子版)

中华危重症医学杂志(电子版) ›› 2022, Vol. 15 ›› Issue (02) : 118 -121. doi: 10.3877/cma.j.issn.1674-6880.2022.02.005

论著

绝经后女性冠状动脉钙化患者的相关危险因素分析
吴聪聪1,†(), 李开军2, 徐剑3, 林莉3   
  1. 1. 323000　浙江丽水，丽水市中心医院妇产科
    2. 323000　浙江丽水，丽水市中心医院全科医学科
    3. 323000　浙江丽水，丽水市中心医院心血管内科
  • 收稿日期:2021-12-29 出版日期:2022-04-30
  • 通信作者: 吴聪聪
  • 基金资助:
    浙江省中医药科学研究基金项目(2020ZB301)

Risk factor analysis of coronary artery calcification in postmenopausal women

Congcong Wu1,†(), Kaijun Li2, Jian Xu3, Li Lin3   

  1. 1. Department of Obstetrics and Gynecology, the Central Hospital of Lishui City, Lishui 323000, China
    2. Department of General Medicine, the Central Hospital of Lishui City, Lishui 323000, China
    3. Department of Cardiovascular Medicine, the Central Hospital of Lishui City, Lishui 323000, China
  • Received:2021-12-29 Published:2022-04-30
  • Corresponding author: Congcong Wu
全文 ( ) 下载PDF ( ) 导出引用
引用本文：

吴聪聪, 李开军, 徐剑, 林莉. 绝经后女性冠状动脉钙化患者的相关危险因素分析[J/OL]. 中华危重症医学杂志(电子版), 2022, 15(02): 118-121.

Congcong Wu, Kaijun Li, Jian Xu, Li Lin. Risk factor analysis of coronary artery calcification in postmenopausal women[J/OL]. Chinese Journal of Critical Care Medicine(Electronic Edition), 2022, 15(02): 118-121.

目的

探讨影响绝经后女性患者发生冠状动脉钙化的相关危险因素。

方法

选取2020年1月至2020年12月行冠状动脉CT血管造影术的121例绝经后女性患者。根据冠状动脉钙化评分（CACS）将所有患者分成钙化组（CACS>10分，57例）及非钙化组（CACS ≤ 10分，64例）。对两组患者的一般资料进行比较，并检测所有患者的雌二醇、促黄体生成素（LH）、卵泡刺激素（FSH）、载脂蛋白A1（APOA1）、载脂蛋白A2（APOA2）、脂蛋白A、胆固醇、高密度脂蛋白（HDL）及低密度脂蛋白（LDL）水平。同时，采用Logistic多因素回归分析影响绝经后女性冠状动脉钙化的危险因素。

结果

与非钙化组比较，钙化组患者的年龄[（54 ± 9）岁vs.（60 ± 11）岁，t = 3.031，P = 0.003]、胆固醇[（5.2 ± 0.5）mmol/L vs.（5.6 ± 0.9）mmol/L，t = 3.410，P = 0.001]及LDL[（2.5 ± 0.6）mmol/L vs.（3.0 ± 0.7）mmol/L，t = 3.790，P< 0.001]水平显著升高，雌二醇[（26 ± 19）ng/L vs.（17 ± 11）ng/L，t = 3.052，P = 0.003]及脂蛋白A[（232 ± 36）mg/L vs.（144 ± 21）mg/L，t = 2.047，P = 0.043]水平均显著降低。Logistic回归分析表明，年龄[比值比（OR）= 1.046，95%置信区间（CI）（1.001，1.094），P = 0.047]及胆固醇[OR = 2.040，95%CI（1.034，4.025），P = 0.040]为绝经后女性冠状动脉钙化的危险因素，雌二醇则为绝经后女性冠状动脉钙化的保护因素[OR = 0.993，95%CI（0.984，0.998），P = 0.049]。

结论

年龄及胆固醇水平为绝经后女性冠状动脉钙化的危险因素，雌二醇则为绝经后女性冠状动脉钙化的保护因素。

关键词: 女性, 绝经, 冠状动脉疾病, 危险因素
Objective

To analyze the risk factors of coronary artery calcification in postmenopausal women.

Methods

A total of 121 postmenopausal women who underwent coronary CT angiography from January 2020 to December 2020 were selected in this study. According to the coronary artery calcification score (CACS), all patients were divided into a calcified group (CACS > 10, n = 57) and a non-calcified group (CACS ≤ 10, n = 64). The general data of the two groups were compared, and the estradiol, luteinizing hormone (LH), follicle stimulating hormone (FSH), apolipoprotein A1 (APOA1), apolipoprotein A2 (APOA2), lipoprotein A, cholesterol, high density lipoprotein (HDL) and low density lipoprotein (LDL) levels were detected in all patients. Meanwhile, the risk factors for coronary artery calcification in postmenopausal women were analyzed by multivariate Logistic regression.

Results

In the calcified group, the age [(60 ± 11) vs. (54 ± 9), t = 3.031, P = 0.003], levels of cholesterol [(5.6 ± 0.9) mmol/L vs. (5.2 ± 0.5) mmol/L, t = 3.410, P = 0.001] and LDL [(3.0 ± 0.7) mmol/L vs. (2.5 ± 0.6) mmol/L, t = 3.790, P< 0.001] were much higher than those in the non-calcified group, while the levels of estradiol [(17 ± 11) ng/L vs. (26 ± 19) ng/L, t = 3.052, P = 0.003] and lipoprotein A [(144 ± 21) mg/L vs. (232 ± 6) mg/L, t = 2.047, P = 0.043] were much lower. The Logistic regression analysis revealed that age [odds ratio (OR) = 1.046, 95% confidence interval (CI) (1.001, 1.094), P = 0.047] and cholesterol [OR = 2.040, 95%CI (1.034, 4.025), P = 0.040] were risk factors for coronary artery calcification in postmenopausal women, while estradiol was a protective factor [OR = 0.993, 95%CI (0.984, 0.998), P = 0.049].

Conclusion

Age and cholesterol are risk factors for coronary artery calcification in postmenopausal women, while estradiol is a protective factor.

Key words: Women, Postmenopause, Coronary artery disease, Risk factors
表1 两组绝经后女性患者一般资料的比较
组别 例数 年龄（岁，± s） BMI<24 kg/m2[例（%）] 糖尿病病史[例（%）] 高血压病史[例（%）] 饮酒史[例（%）]
非钙化组 64 54 ± 9 56（87.5） 30（46.9） 36（56.2） 6（9.4）
钙化组 57 60 ± 11 48（84.2） 32（56.1） 33（57.9） 4（7.0）
t/χ2值   3.031 0.270 1.036 0.033 0.221
P值   0.003 0.603 0.309 0.855 0.638
表2 两组绝经后女性患者相关实验室指标的比较（± s）
组别 例数 雌二醇（ng/L） LH（IU/L） FSH（U/L） APOA1（g/L） APOA2（g/L） 脂蛋白A（mg/L） 胆固醇（mmol/L） HDL（mmol/L） LDL（mmol/L）
非钙化组 64 26 ± 19 15.9 ± 1.6 37 ± 4 1.47 ± 0.31 1.02 ± 0.19 232 ± 36 5.2 ± 0.5 1.17 ± 0.33 2.5 ± 0.6
钙化组 57 17 ± 11 18.8 ± 1.7 44 ± 4 1.44 ± 0.24 1.07 ± 0.19 144 ± 21 5.6 ± 0.9 1.18 ± 0.27 3.0 ± 0.7
t值   3.052 1.237 1.214 0.669 1.163 2.047 3.410 0.240 3.790
P值   0.003 0.219 0.227 0.505 0.247 0.043 0.001 0.811 <0.001
表3 影响绝经后女性患者冠状动脉钙化的Logistic多因素回归分析
变量 回归系数 标准误 Wald值 P值 OR值 95%CI
年龄（岁） 0.045 0.023 3.955 0.047 1.046 1.001~1.094
雌二醇（ng/L） -0.002 0.001 3.898 0.049 0.993 0.984~0.998
脂蛋白A（mg/L） -0.024 0.016 2.127 0.145 0.977 0.946~1.008
胆固醇（mmol/L） 0.713 0.347 4.232 0.040 2.040 1.034~4.025
LDL（mmol/L） 0.726 0.371 3.805 0.051 2.067 0.998~4.280
1
CapranzanoP, AngiolilloDJ.Antithrombotic management of elderly patients with coronary artery disease[J].JACC Cardiovasc Interv,2021,14 (7):723-738.
2
MeyerMR.Chronic coronary syndromes in women: challenges in diagnosis and management[J].Mayo Clin Proc,2021,96 (4):1058-1070.
3
LiY, ZhaoD, WangM,et al.Combined effect of menopause and cardiovascular risk factors on death and cardiovascular disease: a cohort study[J].BMC Cardiovasc Disord,2021,21 (1):109.
4
LeeW, YoonYE, ChoSY,et al.Sex differences in coronary artery calcium progression: the Korea Initiatives on Coronary Artery Calcification (KOICA) registry[J].PLoS One,2021,16 (4):e0248884.
5
AgatstonAS, JanowitzWR, HildnerFJ,et al.Quantification of coronary artery calcium using ultrafast computed tomography[J].J Am Coll Cardiol,1990 (15):827-832.
6
PennCA, ChanJ, MesarosC,et al.Association of serum androgens and coronary artery calcium scores in women[J].Fertil Steril,2019,112 (3):586-593.
7
ZhouM, WangH, ZengX,et al.Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the global burden of disease study 2017[J].Lancet,2019,394 (10204):1145-1158.
8
YoshidaY, ChenZ, BaudierRL,et al.Early menopause and cardiovascular disease risk in women with or without type 2 diabetes: a pooled analysis of 9,374 postmenopausal women[J].Diabetes care,2021,44 (11):2564-2572.
9
DipaMI, NessaA, FirozS,et al.Study on body mass index, serum C-reactive protein and their association with cardiovascular risk factors in postmenopausal women[J].Mymensingh Med J,2021,30 (2):307-314.
10
SwabeG, MatthewsK, BrooksM,et al.High-density lipoprotein cholesterol and arterial calcification in midlife women: the contribution of estradiol and C-reactive protein[J].Menopause,2020,28 (3):237-246.
11
徐慧, 李志刚, 张毅刚, 等. 血浆可溶性致癌抑制因子2联合Gensini评分对急性冠状动脉综合征患者的临床价值[J/CD]. 中华危重症医学杂志(电子版) , 2019, 12 (6) : 383-388.
12
El KhoudarySR, AggarwalB, BeckieTM,et al.Menopause transition and cardiovascular disease risk: implications for timing of early prevention: a scientific statement from the American Heart Association[J].Circulation,2020,142 (25):e506-e532.
13
HuoX, KrumholzHM, BaiX,et al.Effects of mobile text messaging on glycemic control in patients with coronary heart disease and diabetes mellitus: a randomized clinical trial[J].Circ Cardiovasc Qual Outcomes,2019,12 (9):e005805.
14
王弘宇, 王腾玉, 田野. 血管周围脂肪组织在冠状动脉粥样硬化中的作用及评价指标[J]. 中华心血管病杂志, 2021, 49 (9) : 930-934.
15
Al-MuhaidbSM, AljebreenAMM, AlZamelZA,et al.Prevalence of noncalcified plaques and coronary artery stenosis in patients with coronary calcium scores of zero[J].Coron Artery Dis,2021,32 (3):179-183.
16
HaoW, WangX, FanJ,et al.Association between apnea-hypopnea index and coronary artery calcification: a systematic review and meta-analysis[J].Ann Med,2021,53 (1):302-317.
17
张强, 程铖, 徐日新, 等. 中性粒细胞与淋巴细胞比值对ST段抬高型心肌梗死患者直接经皮冠状动脉介入治疗后微循环障碍的预测价值[J/CD]. 中华危重症医学杂志(电子版) , 2020, 13 (5) : 351-355.
[1] 明昊, 肖迎聪, 巨艳, 宋宏萍. 乳腺癌风险预测模型的研究现状[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(05): 287-291.
[2] 黄鸿初, 黄美容, 温丽红. 血液系统恶性肿瘤患者化疗后粒细胞缺乏感染的危险因素和风险预测模型[J/OL]. 中华实验和临床感染病杂志(电子版), 2024, 18(05): 285-292.
[3] 罗文斌, 韩玮. 胰腺癌患者首次化疗后中重度骨髓抑制的相关危险因素分析及预测模型构建[J/OL]. 中华普通外科学文献(电子版), 2024, 18(05): 357-362.
[4] 贺斌, 马晋峰. 胃癌脾门淋巴结转移危险因素[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 694-699.
[5] 刘柏隆. 女性压力性尿失禁阶梯治疗之手术治疗方案选择[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 126-126.
[6] 刘柏隆, 周祥福. 女性尿失禁吊带手术并发症处理的经验分享[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 127-127.
[7] 林凯, 潘勇, 赵高平, 杨春. 造口还纳术后切口疝的危险因素分析与预防策略[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 634-638.
[8] 杨闯, 马雪. 腹壁疝术后感染的危险因素分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 693-696.
[9] 周艳, 李盈, 周小兵, 程发辉, 何恒正. 不同类型补片联合Nissen 胃底折叠术修补食管裂孔疝的疗效及复发潜在危险因素[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(05): 528-533.
[10] 张伟伟, 陈启, 翁和语, 黄亮. 随机森林模型预测T1 期结直肠癌淋巴结转移的初步研究[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(05): 389-393.
[11] 司楠, 孙洪涛. 创伤性脑损伤后肾功能障碍危险因素的研究进展[J/OL]. 中华脑科疾病与康复杂志(电子版), 2024, 14(05): 300-305.
[12] 颜世锐, 熊辉. 感染性心内膜炎合并急性肾损伤患者的危险因素探索及死亡风险预测[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 618-624.
[13] 李文哲, 王毅, 崔建, 郑启航, 王靖彦, 于湘友. 新疆维吾尔自治区重症患者急性肾功能异常的危险因素分析[J/OL]. 中华卫生应急电子杂志, 2024, 10(05): 269-276.
[14] 刘志超, 胡风云, 温春丽. 山西省脑卒中危险因素与地域的相关性分析[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(05): 424-433.
[15] 曹亚丽, 高雨萌, 张英谦, 李博, 杜军保, 金红芳. 儿童坐位不耐受的临床进展[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(05): 510-515.
阅读次数
全文


摘要

版权所有 中华医学会 中华医学电子音像出版社有限责任公司  京ICP备14006079号-1  网络出版服务许可证：(署)网出证(京)字第075号